Hamlet PharmaHamlet PharmaHamlet Pharma
  • Home
  • About Hamlet Pharma
    • Finance and Strategy
    • Patents
    • Who Gets Cancer
  • Clinical Trials
  • Science
  • Investors
    • Financial Reports
    • Extra bolagsstämma 2 mars 2021
  • News
  • Contact
Hamlet Pharma
All Posts By

Hamlet Pharma

Pressmeddelande

Hamlet Pharma tillförs 12,95 miljoner kronor

NewsPressmeddelande

HAMLET Pharma initiates a GLP study to evaluate if intracerebral infusion of the drug candidate Alpha1H has any toxic effects

News

Hamlet building the case for ‘bulldozer’ cancer drug

Previous 1 2 3

HAMLET Pharma AB is a pharmaceutical company with strong links to research, working with natural and biological substances.

Swedish

© 2021 Hamlet Pharma.

  • Home
  • About Hamlet Pharma
    • Finance and Strategy
    • Patents
    • Who Gets Cancer
  • Clinical Trials
  • Science
  • Investors
    • Financial Reports
    • Extra bolagsstämma 2 mars 2021
  • News
  • Contact

Hamlet Pharma AB

BMC D10
Klinikgatan 32
SE-222 42 Lund, Sweden
+46 40 12 25 00
info@hamletpharma.com

Swedish